ResearcherLupin Pharmaceuticals (India)Active in the last 2 years
Mandar Bhonde
Matched on OpenAlex author ID A5113738402. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 1
2023: 1 paper · 2024: none · 2025: 1 paper
Papers 2
- Corrigendum to "PAK4 inhibition significantly potentiates gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathway… Last author DOI 10.1016/j.bbrep.2025.102201↗
- PAK4 inhibition significantly potentiates Gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways. Last author DOI 10.1016/j.bbrep.2023.101544↗
Closest collaborators
The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Charudatt Samant · 2 shared papers, 2023–2025 · strength 0.52
- Paper Corrigendum to "PAK4 inhibition significantly potentiates gemcitabine activity in PDAC cells via inhibition of Wnt/β-ca… DOI 10.1016/j.bbrep.2025.102201↗
- Paper PAK4 inhibition significantly potentiates Gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAP… DOI 10.1016/j.bbrep.2023.101544↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.